Live Breaking News & Updates on Centre For Affective Disorders
Stay updated with breaking news from Centre for affective disorders. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Neurocentrx Reports Positive Top-line Results from Phase 1 Clinical Study of its Lead Oral Ketamine Capsule Programme finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Janssen reveals new Spravato data pharmatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmatimes.com Daily Mail and Mail on Sunday newspapers.
Phase 1 completed with data readout to be reported in Q3 2023 Preliminary data indicates good safety and tolerance up to highest dose Neurocentrx (the Company), a biopharmaceutical company specialising ....
Neurocentrx Provides Update on Clinical Progress of Lead Programme, Keticap®, an Oral Ketamine Formulation for the Treatment of Mood Disorders streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.